^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Oncorine (recombinant human adenovirus type 5)

i
Associations
Company:
Mergen Ltd.
Drug class:
p53 stimulant
Associations
Phase 4
First Affiliated Hospital Xi'an Jiaotong Univer...
Active, not recruiting
Last update posted :
01/27/2022
Initiation :
12/28/2021
Primary completion :
12/01/2023
Completion :
12/01/2023
AFP
|
sorafenib • Oncorine (recombinant human adenovirus type 5)
Phase 3
Xinqiao Hospital of Chongqing
Unknown status
Last update posted :
10/21/2016
Initiation :
10/01/2016
Primary completion :
06/01/2018
Completion :
12/01/2018
EGFR • MUC16
|
cisplatin • gemcitabine • paclitaxel • pemetrexed • vinorelbine tartrate • Endostar (recombinant human endostatin) • Oncorine (recombinant human adenovirus type 5)